As part of its 2018 funding cycle, the National Headache Foundation has awarded a $100,000 grant to fund a nationwide study conducted by Dr. Erin Buchanan of Harrisburg University of Science and Technology and Clinvest Research. The goal of the project will be to improve the way in which migraine treatments are evaluated. The research project enabled by this grant will use modern research techniques and patient input into the design of a new research measure of relief from migraine prevention medications. It will focus on the factors most important to patients as they evaluate response to treatment. Many currently employed measures of relief have not adequately identified or taken into account these factors. This new measurement tool will fill a knowledge gap that could prove to be very helpful to patients, researchers, and clinicians who care about migraine disability and the quality of life of those most impacted by it. Through the development process, researchers are assessing feedback provided by patients with migraine in order to learn more about their priorities and unmet needs so as to enable development and evaluation of better treatment options. In doing so, the hope is that the new assessment instruhttps://headaches.org/read-stories/ment that emerges from this research will be helpful in understanding patients’ responses to medications and also in improving communication between healthcare providers and patients.
View previous recipients of NHF grants here.
